Concepts (51)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| B7-H1 Antigen | 1 | 2016 | 54 | 0.510 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2016 | 65 | 0.510 |
Why?
|
| Herpesvirus 4, Human | 1 | 2016 | 178 | 0.470 |
Why?
|
| B-Lymphocytes | 1 | 2016 | 551 | 0.430 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2013 | 13 | 0.430 |
Why?
|
| Papanicolaou Test | 1 | 2013 | 42 | 0.420 |
Why?
|
| Biomarkers, Tumor | 1 | 2016 | 461 | 0.410 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2013 | 135 | 0.390 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2013 | 237 | 0.360 |
Why?
|
| Adenocarcinoma | 1 | 2013 | 323 | 0.350 |
Why?
|
| Cohort Studies | 2 | 2016 | 2378 | 0.160 |
Why?
|
| Tumor Microenvironment | 1 | 2016 | 140 | 0.120 |
Why?
|
| Lymphoma, T-Cell | 1 | 2015 | 22 | 0.120 |
Why?
|
| Aged, 80 and over | 2 | 2016 | 5138 | 0.120 |
Why?
|
| Neoplasm Staging | 1 | 2016 | 448 | 0.120 |
Why?
|
| Survival Analysis | 1 | 2016 | 554 | 0.120 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2015 | 70 | 0.120 |
Why?
|
| DNA Mismatch Repair | 1 | 2015 | 31 | 0.120 |
Why?
|
| Diaphragm | 1 | 2014 | 21 | 0.110 |
Why?
|
| Tissue Embedding | 1 | 2013 | 3 | 0.110 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 1034 | 0.110 |
Why?
|
| Automation | 1 | 2013 | 51 | 0.110 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2013 | 28 | 0.110 |
Why?
|
| Radiosurgery | 1 | 2014 | 61 | 0.100 |
Why?
|
| Genome, Human | 1 | 2015 | 225 | 0.100 |
Why?
|
| Biopsy, Needle | 1 | 2013 | 134 | 0.100 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 474 | 0.100 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2014 | 167 | 0.100 |
Why?
|
| Prognosis | 1 | 2016 | 1602 | 0.100 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 851 | 0.090 |
Why?
|
| Liver Neoplasms | 1 | 2014 | 276 | 0.090 |
Why?
|
| Transcription, Genetic | 1 | 2015 | 841 | 0.090 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 2344 | 0.090 |
Why?
|
| Aged | 3 | 2016 | 13453 | 0.090 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 939 | 0.090 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 1099 | 0.090 |
Why?
|
| Adult | 2 | 2016 | 15725 | 0.070 |
Why?
|
| Middle Aged | 2 | 2016 | 16373 | 0.070 |
Why?
|
| Transcription Factors | 1 | 2015 | 1471 | 0.070 |
Why?
|
| Young Adult | 1 | 2016 | 4283 | 0.070 |
Why?
|
| Adolescent | 1 | 2016 | 5859 | 0.060 |
Why?
|
| Retrospective Studies | 1 | 2013 | 6109 | 0.050 |
Why?
|
| Humans | 4 | 2016 | 59546 | 0.050 |
Why?
|
| Male | 2 | 2016 | 27838 | 0.040 |
Why?
|
| Immunoblotting | 1 | 2015 | 190 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 191 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 145 | 0.030 |
Why?
|
| Transfection | 1 | 2015 | 675 | 0.030 |
Why?
|
| Female | 1 | 2013 | 30823 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 1367 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 858 | 0.020 |
Why?
|